Vikram Deshpande Selected Research

Immune Checkpoint Inhibitors

1/2022	Case Report: Fulminant Celiac Disease With Combination Immune Checkpoint Therapy.
1/2020	Immune-related adverse events in the gastrointestinal tract: diagnostic utility of upper gastrointestinal biopsies.
11/2019	Budesonide treatment for microscopic colitis from immune checkpoint inhibitors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vikram Deshpande Research Topics

Disease

105	Neoplasms (Cancer) 11/2022 - 04/2003
33	Adenocarcinoma 11/2022 - 12/2006
28	Immunoglobulin G4-Related Disease 10/2022 - 10/2007
17	Neoplasm Metastasis (Metastasis) 11/2022 - 03/2010
15	Cholangiocarcinoma 01/2022 - 01/2012
13	Fibrosis (Cirrhosis) 12/2021 - 05/2011
12	Inflammation (Inflammations) 01/2022 - 10/2007
12	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020 - 09/2012
10	Autoimmune Pancreatitis 01/2019 - 12/2006
9	Carcinoma (Carcinomatosis) 11/2022 - 05/2007
5	Osteosarcoma (Osteogenic Sarcoma) 10/2020 - 06/2013
5	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2019 - 03/2008
4	Colorectal Neoplasms (Colorectal Cancer) 07/2022 - 01/2017
4	Virus Diseases (Viral Diseases) 01/2022 - 08/2020
4	COVID-19 12/2021 - 08/2020
4	Chordoma 01/2021 - 10/2007
4	Disease Progression 01/2021 - 01/2015
4	Adenoma (Adenomas) 01/2020 - 01/2008
4	Polyps 01/2020 - 01/2008
4	Chronic Pancreatitis 01/2019 - 12/2006
4	Phlebitis 06/2018 - 11/2012
4	Cysts 05/2012 - 04/2008
3	Barrett Esophagus (Barrett's Esophagus) 01/2022 - 03/2007
3	Margins of Excision 01/2021 - 07/2012
3	Carcinogenesis 02/2020 - 06/2016
3	Liver Neoplasms (Liver Cancer) 01/2020 - 09/2014
3	Primitive Neuroectodermal Tumors (PNET) 01/2019 - 03/2008
3	Metaplasia 01/2017 - 04/2008
3	Stomach Neoplasms (Stomach Cancer) 01/2016 - 01/2010
2	Papillomavirus Infections 01/2022 - 10/2016
2	Chondrosarcoma 01/2021 - 06/2013
2	Lymphadenopathy 01/2021 - 05/2018
2	Colonic Neoplasms (Colon Cancer) 01/2021 - 01/2017
2	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 01/2015
2	Sarcoma (Soft Tissue Sarcoma) 11/2020 - 01/2019
2	Colitis 11/2019 - 04/2010
2	Microscopic Colitis 11/2019 - 04/2013
2	Spontaneous Fractures (Pathological Fracture) 09/2019 - 01/2019

Drug/Important Bio-Agent (IBA)

35	Immunoglobulin G (IgG)IBA 10/2022 - 12/2006
26	RNA (Ribonucleic Acid)IBA 10/2022 - 09/2014
19	Biomarkers (Surrogate Marker)IBA 11/2022 - 03/2010
17	Proteins (Proteins, Gene)FDA Link 11/2022 - 09/2014
10	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 03/2008
9	Rituximab (Mabthera)FDA Link 01/2020 - 06/2010
8	Messenger RNA (mRNA)IBA 01/2022 - 01/2015
8	folfirinoxIBA 11/2021 - 01/2015
8	AlbuminsIBA 01/2020 - 01/2015
7	Immunoglobulins (Immunoglobulin)IBA 01/2022 - 10/2007
6	MucinsIBA 11/2022 - 04/2008
6	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2022 - 01/2012
6	Coloring Agents (Dyes)IBA 01/2021 - 10/2009
6	Biological ProductsIBA 09/2019 - 03/2009
5	EnzymesIBA 01/2022 - 01/2012
5	DesminIBA 01/2019 - 09/2013
5	SteroidsIBA 08/2018 - 10/2009
4	LigandsIBA 11/2022 - 01/2016
4	InterferonsIBA 01/2022 - 08/2020
4	Keratins (Keratin)IBA 12/2021 - 01/2018
4	ParaffinIBA 01/2021 - 02/2011
3	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 10/2022 - 01/2019
3	IntegrinsIBA 04/2022 - 09/2012
3	Immune Checkpoint InhibitorsIBA 01/2022 - 11/2019
3	Eosine Yellowish-(YS) (Eosin)IBA 10/2021 - 10/2007
3	Hematoxylin (Haematoxylon)IBA 10/2021 - 10/2007
3	Histocompatibility Antigens Class IIBA 01/2021 - 01/2016
3	AntigensIBA 01/2021 - 01/2014
3	Denosumab FDA Link 12/2020 - 01/2016
3	MicroRNAs (MicroRNA)IBA 10/2020 - 06/2016
3	Brachyury protein (Brachyury)IBA 01/2020 - 01/2011
3	CollagenIBA 01/2020 - 12/2015
3	AntibodiesIBA 01/2020 - 01/2014
3	ChromatinIBA 01/2019 - 02/2007
3	Transcription Factors (Transcription Factor)IBA 01/2019 - 11/2014
3	Phosphotransferases (Kinase)IBA 01/2019 - 11/2014
3	Pharmaceutical PreparationsIBA 01/2016 - 04/2010
2	AgrinIBA 01/2022 - 01/2020
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022 - 01/2015
2	Nucleic AcidsIBA 01/2022 - 11/2014
2	ElementsIBA 01/2022 - 01/2017
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2021 - 01/2019
2	Formaldehyde (Formol)FDA Link 01/2021 - 02/2011
2	HLA-A Antigens (HLA-A)IBA 01/2021 - 01/2019
2	Leucovorin (Folinic Acid)FDA Link 01/2021 - 07/2020
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021 - 07/2020
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2021 - 07/2020
2	Fluorouracil (Carac)FDA LinkGeneric 01/2021 - 07/2020
2	Circular RNAIBA 02/2020 - 01/2019
2	ChemokinesIBA 01/2020 - 01/2019
2	theasinensin AIBA 01/2020 - 01/2008
2	GlucocorticoidsIBA 11/2019 - 01/2012
2	infigratinibIBA 01/2019 - 01/2017
2	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2019 - 01/2017

Therapy/Procedure

36	Therapeutics 11/2022 - 01/2009
9	Neoadjuvant Therapy 11/2022 - 11/2012
7	Drug Therapy (Chemotherapy) 11/2022 - 09/2012
5	Pancreatectomy 01/2022 - 01/2008
5	Immunotherapy 10/2021 - 01/2016
3	Adjuvant Chemotherapy 01/2021 - 06/2013
3	Pancreaticoduodenectomy 12/2019 - 01/2008
2	Hepatectomy 01/2021 - 10/2009